This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: The Effects of Tyrosine Kinase Inhibitors (TKIs) in Monotherapy and with Add-on Treatments on Health-related Quality of Life of People with Chronic Myeloid Leukemia: A Systematic Review of Randomized-Controlled Trials, Clinical Practice and Epidemiology in Mental Health, January 2023, Bentham Science Publishers,
DOI: 10.2174/17450179-v17-e211118-2021-ht2-1910-12.
You can read the full text:
The following have contributed to this page
